Hologic, Inc.: Hologic Announces European CE Mark for Molecular Assays for Use with Transplant Patients
-- New quantitative assays for Epstein-Barr Virus and BK Virus expand Hologic's Panther Fusion transplant pathogen monitoring menu -- Hologic, Inc. (Nasdaq: HOLX) announced it has received CE marking
United States Jane Mazur Bryan Simon Jan Verstreken Corporate Communications Infectious Diseases Community Of Practice
Source: finanznachrichten.de